Dementia in Parkinson's disease challenges the “gold standard”

cance of early ischemic changes on computed tomography in acute stroke. JAMA 2001;286:2830–2838. 9. Hill MD, von Kummer R, Levine S, et al. ASPECT overview of NINDS, ECASS, and ATLANTIS. TAST Symposium, Whistler, Canada. June 21–22, 2004. 10. Zimmerman RD. Stroke wars: episode IV CT strikes back. AJNR Am J Neuroradiol 2004;25:1304–1309. 11. Latchaw RE, Yonas H, Hunter GJ, et al. Guidelines and recommendations for perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003;34:1084–1104. 12. Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54:773–782. 13. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 1981;12:723–725. 14. Baron JC, von KR, del Zoppo GJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window. Stroke 1995;26:2219–2221. 15. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363: 768–774. 16. NINDS Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581–1587. 17. Michel P, Reichhart M, Wintermark M, et al. [Stroke management using perfusion-CT]. Schweiz Arch Neurol Psych 2004; 155:148–151. 18. Gerraty RP, Parsons MW, Barber PA, et al. Examining the lacunar hypothesis with diffusion and perfusion magnetic resonance imaging. Stroke 2002;33:2019–2024. 19. Yamada M, Yoshimura S, Kaku Y, et al. Prediction of neurologic deterioration in patients with lacunar infarction in the territory of the lenticulostriate artery using perfusion CT. AJNR Am J Neuroradiol 2004;25:402–408. 20. Ueda T, Hatakeyama T, Kumon Y, et al. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994;25: 298–303. 21. Goldstein S, Yonas H, Gebel JM, et al. Acute cerebral blood flow as a predictive physiologic marker for symptomatic hemorrhagic conversion and clinical herniation after thrombolytic therapy. Stroke 2000;31:275–283. 22. Bezerra DC, Reichhart MD, Wintermark M, et al. The volume of perfusion defect within 3 hours of stroke onset is a predictor of intracranial hemorrhage after iv rt-PA therapy. Neurology 2005;64(suppl 1):A264. 23. Hacke W, Albers G, Al-Rawi Y, et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73. 24. Ribo M, Molina CA, Rovira A, et al. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3to 6-hour window using multimodal transcranial Doppler/ MRI selection protocol. Stroke 2005;36:602–606. 25. Fiehler J, Kucinski T, Knudsen K, et al. Are there timedependent differences in diffusion and perfusion within the first 6 hours after stroke onset? Stroke 2004;35:2099–2104. 26. Menezes NM, Ay H, Lopez CJ, et al. Predicting stroke clinical outcome in the nondominant hemisphere using MRI. Stroke 2005;36:441. 27. Lee JM, Vo KD, An H, et al. Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003;53:227–232. 28. Parsons MW, Li T, Barber PA, et al. Combined (1)H MR spectroscopy and diffusion-weighted MRI improves the prediction of stroke outcome. Neurology 2000;55:498–505.